Epigenetic Modifications are Instrumental for Improving Overall Research and Management of Osteosarcoma in the Framework of 3P Medicine
Journal of Neuro and Oncology Research · 29.06.2026 · 6 (2) · 1-28
DOI: 10.46889/jnor.2026.6205 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neuro and Oncology Research, online erschienen am 29.06.2026. Verfasst von Arshad Ali und 4 weiteren Autor:innen. Die Arbeit nennt 204 Literaturangaben.
Abstract (Originalsprache)
Osteosarcoma is characterized as the most aggressive malignant bone cancer in infants and adolescents. Due to advanced therapeutic outcomes, the survival rate of 5 years is still nearly 60% if it is diagnosed early and can prescribe enervating treatments, e.g. amputations. A complete knowledge of the disease can assist in enriching clinical consequences for osteosarcoma patients. One propitious approach of osteosarcoma investigation is the discipline of epigenetics. Epigenetics, a key discipline that mainly describes the distinctive countenance of phenotypes emerging from the constant sequence of genes and the congenital of epigenetic modification, has acquired much devotion in prescription. Epigenetic modifications e.g. DNA methylation, histone alteration, ubiquitination, noncoding RNAs and m6A are widely intricate in the growth and progression of human cancers. Current study highlights how epigenetic profiles modified proteoforms to determine osteosarcoma prediction, prevention and prescribe personalized medicine to improve patient outcomes. Underlines many epigenetic target genes and molecular networks mechanisms that regulate different angles of osteosarcoma, including metastasis, propagation, infiltration and chemotherapy resistance. Current review emphasized the recent advancement in epigenetic regulation targeting the proteoforms of osteosarcoma and elaborated the clinical outcomes in the discipline of Predictive, Preventive as well as Personalized Medicine (PPPM; 3PM).
Zitieren
APA
Ali, A., Ali, A., Zhang, Y., Fang, Z., & Zhan, X. (2026). Epigenetic Modifications are Instrumental for Improving Overall Research and Management of Osteosarcoma in the Framework of 3P Medicine. Journal of Neuro and Oncology Research, 6(2), 1-28. https://doi.org/10.46889/jnor.2026.6205
Vancouver
Ali A, Ali A, Zhang Y, Fang Z, Zhan X. Epigenetic Modifications are Instrumental for Improving Overall Research and Management of Osteosarcoma in the Framework of 3P Medicine. Journal of Neuro and Oncology Research. 2026;6(2):1-28. doi:10.46889/jnor.2026.6205
BibTeX
@article{Ali2026,
author = {Ali, Arshad and Ali, Ayaz and Zhang, Yuping and Fang, Zheng and Zhan, Xianquan},
title = {Epigenetic Modifications are Instrumental for Improving Overall Research and Management of Osteosarcoma in the Framework of 3P Medicine},
journal = {Journal of Neuro and Oncology Research},
year = {2026},
volume = {6},
number = {2},
pages = {1--28},
doi = {10.46889/jnor.2026.6205}
}
EUVIMED